MT-RNR1 and Miyoshi myopathy: This investigation examined the relationship between serum MOTS-c levels and therapeutic outcomes in individuals newly diagnosed with MM, focusing particularly on elevation in MOTS-c among patients who responded to therapy, whereas such changes were absent in refractory cases (Table 2).